Results 101 to 110 of about 1,509 (158)

Effects of D-Chiro-Inositol on Glucose Metabolism in db/db Mice and the Associated Underlying Mechanisms. [PDF]

Front Pharmacol, 2020
Fan C, Liang W, Wei M, Gou X, Han S, Bai J.   +5 more
europepmc   +1 more source

Targeting Metabolic Consequences of Insulin Resistance in Polycystic Ovary Syndrome by D-chiro-inositol and Emerging Nutraceuticals: A Focused Review. [PDF]

J Clin Med, 2020
Davinelli S, Nicolosi D, Di Cesare C, Scapagnini G, Di Marco R.   +4 more
europepmc   +1 more source

Effectiveness of a Food Supplement Based on Glucomannan, D-Chiro-Inositol, Cinnamomum zeylanicum Blume and Inulin in Patients with Metabolic Syndrome. [PDF]

Nutrients
Citarrella R, Chianetta R, Amodeo S, Mirarchi L, Licata A, Soresi M, Veronese N, Barbagallo M, Giannitrapani L.   +8 more
europepmc   +1 more source

D-Chiro-Inositol Treatment Affects Oocyte and Embryo Quality and Improves Glucose Intolerance in Both Aged Mice and Mouse Models of Polycystic Ovarian Syndrome. [PDF]

Int J Mol Sci, 2020
Pericuesta E, Laguna-Barraza R, Ramos-Ibeas P, Gutierrez-Arroyo JL, Navarro JA, Vera K, Sanjuan C, Baixeras E, de Fonseca FR, Gutierrez-Adan A.   +9 more
europepmc   +1 more source

Treatment With a Patented 3.6:1 Myo-Inositol to D-chiro-Inositol Ratio, Antioxidants, Vitamins and Minerals Food Supplement in Women With a History of Assisted Reproductive Technique (ART) Failures: A Series of Case Reports. [PDF]

Clin Med Insights Case Rep
Armijo-Sánchez A, Benítez Castillo N, García-Vidal E, Luna Chadid M, Salvador Ballada C, Valls Ricart G, Torres Pellens V.   +6 more
europepmc   +1 more source

Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study. [PDF]

J Ovarian Res, 2019
Troisi J, Cinque C, Giugliano L, Symes S, Richards S, Adair D, Cavallo P, Sarno L, Scala G, Caiazza M, Guida M.   +10 more
europepmc   +1 more source

D-Chiro-Inositol's action as aromatase inhibitor: rationale and potential clinical targets.

European review for medical and pharmacological sciences, 2019
Laganà AS, Unfer V
openaire   +3 more sources

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. [PDF]

Cochrane Database Syst Rev, 2017
Morley LC, Tang T, Yasmin E, Norman RJ, Balen AH.   +4 more
europepmc   +1 more source

D-chiro-inositol effectively attenuates cholestasis in bile duct ligated rats by improving bile acid secretion and attenuating oxidative stress. [PDF]

Acta Pharmacol Sin, 2018
Zhao SS, Li NR, Zhao WL, Liu H, Ge MX, Zhang YX, Zhao LY, You XF, He HW, Shao RG.   +9 more
europepmc   +1 more source

D-chiro-inositol glycan stimulates insulin secretion in pancreatic β cells. [PDF]

Mol Cell Endocrinol, 2014
Lazarenko R, Geisler J, Bayliss D, Larner J, Li C.   +4 more
europepmc   +1 more source